SOAT1 and COVID-19: Based on the associated molecular mechanisms, combined inhibition of IFN-γ and TNF-α, along with JAK-STAT pathway inhibitors and iNOS inhibitors, presents a novel therapeutic approach for the prevention and treatment of severe COVID-19.